Mylan Generics Header

Generic Products

The first generic medicine we ever made? Penicillin G in 1966. Since then, Mylan has applied one global quality standard across our facilities, and across our product line, regardless of market.

How We Make Generic Medicines at Mylan

  1. Drug Monitoring
    Advanced Monitoring Systems

    Advanced Monitoring Systems

    Although not required, Mylan utilizes state-of-the-art monitoring systems that can automatically evaluate and reject product that does not meet specifications. This advanced technology is used to automatically remove defective product from production or packaging lines.

  2. Drug Standards
    One Global Quality Standard

    One Global Quality Standard

    Whether it’s a medication for millions or for a handful of people, our priorities are to meet or exceed industry standards. Our own teams conduct ongoing reviews to ensure quality and integrity of products, start to finish, and to continually improve for optimal quality and consistency. Because trust goes beyond our global quality standards. It’s all about caring for the people who will be helped by what we do.

  3. Counterfeit Drugs
    Protection Against Defects

    Protection Against Defects

    Quality begins at step one. Mylan uses an established testing and verification process to ensure the suitability of active ingredients used in our medicines.
  4. Proof of Purity and Potency

    Proof of Purity and Potency

    Mylan assures product potency, purity and drug release through expiration date by testing the stability of our products at specific intervals.
  5. GMP Audit Promise
    A Promise to Pharmacists

    A Promise to Pharmacists

    Customers count on you for advice. That's one of the reasons Mylan applies one global quality standard across our facilities and across our product line, regardless of market.

  6. USP Requirements
    A Promise to Physicians

    A Promise to Physicians

    To ensure that you provide your patients with the highest quality medicines, Mylan uses advanced testing and monitoring systems to assure product adheres to testing acceptance criteria that are in alignment with requirements established by standard-setting organizations around the world.

Access Channels +/-

When your mission is to provide 7 billion people access to high quality medicine, how do you get the medicine to them?

At Mylan, we’ve established a broad network of local and global access channels through physicians, institutions, governments, retailers and wholesalers. These are relationships we’ve built and nurtured over decades.

3 Facts +/-

Nearly 80% of U.S. prescriptions are filled with a generic medicine.

One out of every 11 U.S.prescriptions dispensed, brand name or generic, is filled with a Mylan product.

Generic medicines saved the American health care system $1 trillion between 2002 and 2011.

Our Generics History +/-

1970s: By decade’s end, we produced five of the 10 most prescribed generic medicines.

1981: Mylan helps found the Generic Pharmaceutical Industry Association. The group lobbies for the Hatch-Waxman Act—a response to the high price of brand name drugs.

1986: Through congressional testimony, we help expose fraudulent practices between the Food and Drug Administration and several generics companies.

2007: We acquire Merck KGaA’s generics business, which sells products in more than 90 countries.

2012: We help drive the Generic Drug User Fee Amendments and the Food and Drug Administration Safety and Innovation Act. Both help ensure one global quality standard for all medicines entering the United States.

Latest From Mylan

  1. Rabeprazole DR Tablets

    RABEPRAZOLE SODIUM (rabeprazole) tablet, delayed release
    Generic ACIPHEX®

    Click here for Full Prescribing Information

    Strengths: 20 mg

    NDC: 0378-6709-05, 0378-6709-77, 0378-6709-93

    Launch Date: November 8, 2013

  2. Voriconazole Oral Suspension

    VORICONAZOLE- voriconazole tablet, film coated
    Generic Vfend

    Click here for Full Prescribing Information

    Strengths: 40 mg/mL

    NDC: 0378-6270-45

    Launch Date: September 25, 2013

  3. Montelukast Sodium Granules

    MONTELUKAST SODIUM- montelukast sodium tablet, film coated
    Generic Singulair®

    Click here for Full Prescribing Information

    Strengths: 4 mg

    NDC: 0378-6040-93

    Launch Date: September 18, 2013

  4. Repaglinide Tablets

    REPAGLINIDE tablet
    Generic PRANDIN®

    Click here for Full Prescribing Information

    Strengths: 0.5 mg

    NDC: 0378-3121-01, 0378-3121-05

    Launch Date: August 27, 2013


Because there is nothing generic about our standards. Our internal teams conduct reviews of all products, start to finish, no matter where in the world they are made.

Resources and information to help prescribe, dispense and take medicine with confidence

  • Pharmacist CE


    Educational materials to help empower your customers

  • Patient Resources


    What to know about our high quality generics 

  • Patient Education


    Details about our brand name and generic medicines

  • Institutional Resources

    Institutional Customers

    Resources that meet the specific needs of your institution


Find a Mylan Product

Search our generic and brand name U.S. pharmaceuticals.

Institutional Products

We are committed to offering a complete line of reliable, high quality products that are designed to help hospitals and other institutions reduce error, increase efficiency and improve care.

What we offer
Why generics?